Aliza Leiser

1.8k total citations · 1 hit paper
29 papers, 1.2k citations indexed

About

Aliza Leiser is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Aliza Leiser has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 10 papers in Obstetrics and Gynecology and 9 papers in Cancer Research. Recurrent topics in Aliza Leiser's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer survivorship and care (4 papers). Aliza Leiser is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer survivorship and care (4 papers). Aliza Leiser collaborates with scholars based in United States, Australia and United Kingdom. Aliza Leiser's co-authors include Gil Mor, Thomas Rutherford, Ayesha B. Alvero, Peter E. Schwartz, Irene Visintin, Michael Kelly, S. Dennis, Stefan Fest, Ryan Chen and Dan‐Arin Silasi and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Aliza Leiser

27 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

2021 196 citations Matteo Palmeri, Janice M. Mehnert et al. ESMO Open profile →

Peers

Countries citing papers authored by Aliza Leiser

Since Specialization

Citations

This map shows the geographic impact of Aliza Leiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliza Leiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliza Leiser more than expected).

Fields of papers citing papers by Aliza Leiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aliza Leiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliza Leiser. The network helps show where Aliza Leiser may publish in the future.

Co-authorship network of co-authors of Aliza Leiser

This figure shows the co-authorship network connecting the top 25 collaborators of Aliza Leiser. A scholar is included among the top collaborators of Aliza Leiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aliza Leiser. Aliza Leiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Severe Epinephrine-Induced Lactic Acidosis		Aliza Leiser, Paul Kinniry et al.	1
2	Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline	Journal of Clinical Oncology	Praveen Vikas, Hans Messersmith et al.	57
3	Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer	International Journal of Gynecological Cancer	Eugenia Girda, June Y. Hou et al.	8
4	Community-based outpatient cancer rehabilitation services for women with gynecologic cancer: acceptability and impact on patient-reported outcomes	Supportive Care in Cancer	Tiffany Kendig, Aliza Leiser et al.	4
5	Management of Dyspnea in Advanced Cancer: ASCO Guideline	Journal of Clinical Oncology	David Hui, Kari Bohlke et al.	92
6	Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers breakdown →	ESMO Open	Matteo Palmeri, Janice M. Mehnert et al.	196
7	Evaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancer	Gynecologic Oncology	Eugenia Girda, Alexandre Buckley de Meritens et al.	11
8	Ogilvie's Syndrome after Robotic-Assisted Radical Hysterectomy for Cervical Cancer	Journal of Minimally Invasive Gynecology	Theofano Orfanelli, Darlene Gibbon et al.	2
9	Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers	Gynecologic Oncology	Lorna Rodríguez-Rodríguez, Kim M. Hirshfield et al.	25
10	Differential Roles of MAPK-Erk1/2 and MAPK-p38 in Insulin or Insulin-Like Growth Factor-I (IGF-I) Signaling Pathways for Progesterone Production in Human Ovarian Cells	Hormone and Metabolic Research	Donna Seto‐Young, Dimiter Avtanski et al.	11
11	Diagnostic Markers for Early Detection of Ovarian Cancer	Clinical Cancer Research	Irene Visintin, Ziding Feng et al.	307
12	Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells	Oncogene	Ryan Chen, Ayesha B. Alvero et al.	255
13	Clear cell carcinoma of the cervix: A multi-institutional review in the post-DES era	Gynecologic Oncology	Mathew Thomas, Jason D. Wright et al.	53
14	A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer	International Journal of Gynecological Cancer	Aliza Leiser, Fernando Cotait Maluf et al.	13
15	Carcinosarcoma of the ovary treated with platinum and taxane: The memorial Sloan-Kettering Cancer Center experience	Gynecologic Oncology	Aliza Leiser, S. Dennis et al.	51
16	Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer	International Journal of Gynecological Cancer	Fernando Cotait Maluf, Aliza Leiser et al.	27
17	Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer	International Journal of Gynecological Cancer	Fernando Cotait Maluf, Aliza Leiser et al.	8
18	Evaluation and management of gestational trophoblastic disease	Community Oncology	Aliza Leiser, Carol Aghajanian	3
19	Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma	Gynecologic Oncology	Aliza Leiser, Sibyl Anderson et al.	44
20	Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor	Gynecologic Oncology	Aliza Leiser, Rita A. Blanchard et al.	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact